Regulatory Filings • Jun 6, 2002
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 6 June 2002 08:17
aap Implantate AG english
aap Implantate AG is granted U.S. patent for Trauma Shoulder System Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– aap Implantate AG is granted U.S. patent for Trauma Shoulder System Metal and biological implant specialist aap Implantate AG today announced that the U.S. Patent and Trademark Office has granted it a new patent for the Trauma Shoulder System (TSS). U.S. Patent No. 09/672,322, entitled Shoulder Joint Endoprosthesis, applies to the unique fixing mechanism of the prosthesis to the shoulder muscles on the upper arm. The patent was applied for in 2000. Data Monitor estimates that aap has gained access with the TSS patent to a potential U.S. market of roughly $ 93 million. The Trauma Shoulder System opens up totally new ways of treating humerus head fractures because individual muscles are for the first time joined to the implant by a large number of multiple fixing points. This feature enables the surgeon to adjust the implant optimally to the anatomy of the individual patient. The product has already been approved in the European market. Last year, aap estimates, the Trauma Shoulder System secured a market share of roughly 10% in Germany alone. Other TSS patents have been applied for in Europe and major Asian markets. aap Implantate AG currently has 35 patents and design patents in use. They cover aap’s four technology competencies high-tech metal processing, bone cement and cementing techniques, orthobio-logical materials and electro- osteostimulation processes. end of ad-hoc-announcement (c)DGAP 06.06.2002 ——————————————————————————– WKN: 506660; ISIN: DE0005066609; Index: Listed: Neuer Markt Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 060817 Jun 02
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.